Ajinomoto Bio Pharma Services
11040 Roselle St.
About Ajinomoto Bio Pharma Services
At Ajinomoto Bio-Pharma Services, our mission is to help improve the health of humankind. Our ultimate goal is to provide adaptive solutions, responsive service, trusted partnerships and peace of mind to our customers. Through innovation, accountability, compliance, communication and teamwork, we take pride in knowing our efforts are helping countless patients for years to come.
Aji Bio-Pharma Animated Overview
77 articles about Ajinomoto Bio Pharma Services
Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP™.
Ajinomoto Althea, Inc. celebrated its 20th year in operation, making it one of the true anchors of the San Diego life science community.
Ajinomoto Althea, Inc. announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.
Ajinomoto Althea Inc. Opens Manufacturing Suites In New High Potency And Antibody Drug Conjugate Commercial Facility
Biologics Candidate Manufactured Using Ajinomoto Althea Inc.'s CORYNEX Protein Expression System Enters Clinical Trials For The First Time
Ajinomoto Althea Inc. Announces Issuance Of New US Patent For Manufacturing Of Crystal Monoclonal Antibodies
Ajinomoto Althea Inc. Expands Its Capacity Of Fill Finish Manufacturing With Addition Of Second Shift
Ajinomoto Althea Inc. Launches Process And Analytical Development Services For Antibody Drug Conjugates (ADCs) Therapeutics
Ajinomoto Althea Inc. Receives European GMP Certification For Commercial Aseptic Filling And Testing
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production
Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen
Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
Allena Pharmaceuticals, Inc. Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies, Inc.
Althea Technologies, Inc. Appoints Martha J. Demski as Senior Vice President and Chief Financial Officer